Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ready-to-use Dasiglucagon for the Treatment of Postprandial Hypoglycaemia in Roux-en-Y Gastric Bypass Operated Patients

Next Previous
X
Search
Trial Profile

Ready-to-use Dasiglucagon for the Treatment of Postprandial Hypoglycaemia in Roux-en-Y Gastric Bypass Operated Patients

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 13 Oct 2023

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dasiglucagon (Primary)
  • Indications Hypoglycaemia
  • Focus Proof of concept; Therapeutic Use
  • Acronyms SHERRY

    • Most Recent Events

    • 11 Oct 2023 Results assessing Dasiglucagon Treatment for Postprandial Hypoglycemia After Gastric Bypass published in the Diabetes Care
    • 06 Oct 2023 Primary endpoint (Time spent in hypoglycaemia (IG 3.9 mmol)) has been met as per results presented at the 59th Annual Meeting of the European Association for the Study of Diabetes.
    • 06 Oct 2023 Results investigating the efficacy of dasiglucagon on post-bariatric hypoglycaemia, presented at the 59th Annual Meeting of the European Association for the Study of Diabetes.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top